This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jiangsu Kanion Pharmaceutical Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Zhimin Du in Pharmaceutical Chemistry
Introduction
Zhimin Du is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that promote healing in diabetic wounds. His work is characterized by a focus on efficiency and cost-effectiveness in drug preparation.
Latest Patents
Zhimin Du holds a patent for an emodin succinyl ester compound, along with its preparation method and applications. This invention presents a novel compound that has been shown to effectively promote the healing of diabetic wounds, outperforming traditional emodin. The preparation method is straightforward, allowing for industrial production while saving time and reducing costs. The compound has demonstrated a remarkable blood fat-lowering effect in pharmacological experiments, making it a promising candidate for drug development.
Career Highlights
Zhimin Du is associated with Jiangsu Kanion Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has not only advanced the understanding of emodin derivatives but has also contributed to the development of safer and more effective treatments for diabetic wounds.
Collaborations
Zhimin Du has collaborated with notable colleagues, including Baofeng Yang and Wei Xiao. Their combined expertise has further enhanced the research and development efforts within their organization.
Conclusion
Zhimin Du's contributions to pharmaceutical chemistry, particularly through his patented emodin succinyl ester compound, highlight his role as an influential inventor in the field. His work promises to improve treatment options for diabetic wounds and showcases the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile